Correlation Between Pharmaceuticals Ultrasector and Financials Ultrasector
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Financials Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Financials Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Financials Ultrasector Profund, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Financials Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Financials Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Financials Ultrasector.
Diversification Opportunities for Pharmaceuticals Ultrasector and Financials Ultrasector
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pharmaceuticals and Financials is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Financials Ultrasector Profund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Financials Ultrasector and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Financials Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Financials Ultrasector has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Financials Ultrasector go up and down completely randomly.
Pair Corralation between Pharmaceuticals Ultrasector and Financials Ultrasector
Assuming the 90 days horizon Pharmaceuticals Ultrasector is expected to generate 1.72 times less return on investment than Financials Ultrasector. In addition to that, Pharmaceuticals Ultrasector is 1.04 times more volatile than Financials Ultrasector Profund. It trades about 0.1 of its total potential returns per unit of risk. Financials Ultrasector Profund is currently generating about 0.17 per unit of volatility. If you would invest 3,403 in Financials Ultrasector Profund on September 3, 2024 and sell it today you would earn a total of 1,227 from holding Financials Ultrasector Profund or generate 36.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharmaceuticals Ultrasector Pr vs. Financials Ultrasector Profund
Performance |
| Timeline |
| Pharmaceuticals Ultrasector |
| Financials Ultrasector |
Pharmaceuticals Ultrasector and Financials Ultrasector Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharmaceuticals Ultrasector and Financials Ultrasector
The main advantage of trading using opposite Pharmaceuticals Ultrasector and Financials Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Financials Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Financials Ultrasector will offset losses from the drop in Financials Ultrasector's long position.The idea behind Pharmaceuticals Ultrasector Profund and Financials Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Financials Ultrasector vs. American Century Etf | Financials Ultrasector vs. Boston Partners Small | Financials Ultrasector vs. Heartland Value Plus | Financials Ultrasector vs. Royce Opportunity Fund |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |